Advertisement
Research ArticleEndocrine and Diabetes

Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively With Sulfonylureas

Ryo Ito, Yoshiyuki Tsujihata, Masami Suzuki, Kazumasa Miyawaki, Kae Matsuda and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics January 26, 2016, jpet.115.230730; DOI: https://doi.org/10.1124/jpet.115.230730

Data Supplement

Files in this Data Supplement:

  • Supplemental Figure - Glucose-lowering effects and insulinotropic action were also observed with glimepiride.

  View article